CPTech began working on problems relating the data exclusivity in 1991, in connection with the registration of Taxol, an unpatented cancer drug. More information on:
CPT web page on disputes involving Taxol.
CPTech in a number of cases has advocated consideration of compensatory liability or mandatory compulsory licensing of rights in test data, including, for example, October 21, 1997 US Senate hearing and as an option for the CAFTA-US Free Trade Agreement in 2004, available
here.
May 18, 2006. Judit Rius Sanjuan, James Love & Robert Weissman.
A cost sharing model to protect investments in pharmaceutical test data.
CPTech Policy Brief No. 1.
November 21, 2006. Judit Rius Sanjuan, James Love, Robert Weissman.
Protection of Pharmaceutical Test Data: A Policy Proposal. Consumer Project on Technology.
